FDA — authorised 1 February 1977
- Status: approved
🇺🇸 Lorelco in United States
FDA authorised Lorelco on 1 February 1977
Marketing authorisations
FDA — authorised 1 February 1977
- Application: NDA017535
- Marketing authorisation holder: SANOFI AVENTIS US
- Local brand name: LORELCO
- Indication: TABLET — ORAL
- Status: approved
Lorelco in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Lorelco approved in United States?
Yes. FDA authorised it on 1 February 1977; FDA authorised it on 1 February 1977.
Who is the marketing authorisation holder for Lorelco in United States?
Marketing authorisation holder not available in our data.